Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025

ゲノム編集/ゲノムエンジニアリングの世界市場予測(~2025):技術別、製品・サービス別、用途別、エンドユーザー別、地域別

◆タイトル:Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025
◆商品コード:BT 3380
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年6月9日
◆ページ数:148
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社はゲノム編集/ゲノムエンジニアリングの世界市場が2020年51億ドルから2025年112億ドルまで、年平均17.0%成長すると見込んでいます。本調査レポートでは、ゲノム編集/ゲノムエンジニアリングの世界市場を詳細に調査・分析し、イントロダクション、調査手法、プレミアムインサイト、市場概要、技術別(クリスパー、転写活性化様エフェクターヌクレアーゼ、ジンクフィンガーヌクレアーゼ、アンチセンス、その他) 分析、用途別(セルラインエンジニアリング、遺伝子エンジニアリング、診断、薬物発見・開発)分析、製品・サービス別(試薬・消耗品、ソフトウェア・システム、サービス)分析、エンドユーザー別(製薬会社、バイオテクノロジー企業、学術・政府研究機関)分析、地域別分析、競争状況、企業概要などを含めています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・ゲノム編集/ゲノムエンジニアリングの世界市場規模:技術別(クリスパー、転写活性化様エフェクターヌクレアーゼ、ジンクフィンガーヌクレアーゼ、アンチセンス、その他)
・ゲノム編集/ゲノムエンジニアリングの世界市場規模:用途別(セルラインエンジニアリング、遺伝子エンジニアリング、診断、薬物発見・開発)
・ゲノム編集/ゲノムエンジニアリングの世界市場規模:製品・サービス別(試薬・消耗品、ソフトウェア・システム、サービス)
・ゲノム編集/ゲノムエンジニアリングの世界市場規模:エンドユーザー別(製薬会社、バイオテクノロジー企業、学術・政府研究機関)
・ゲノム編集/ゲノムエンジニアリングの世界市場規模:地域別
・競争状況
・企業概要

“Rising government funding and increase in the number of genomic projects, especially in the area of rare diseases, and a growing application horizon are all expected to drive the growth of the genome editing/genome engineering market.”
The global genome editing/genome engineering market is projected to reach USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period. Market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases & cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market.

“CRISPR commanded the largest share of the market in 2019.”
Based on technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies. CRISPR accounted for the largest share of the genome editing/genome engineering market in 2019. The large share of this segment can be attributed to the ease of use associated with the CRISPR technology and its ability to multiplex.

“Pharmaceutical companies commanded the largest share of the genome editing/genome engineering market in 2019.”
By end user, the genome editing/genome engineering market is segmented into pharmaceutical companies, biotechnology companies, and academic & government research institutes. The pharmaceutical companies segment accounted for the largest share of the market. The pharmaceutical companies segment accounted for the largest share of the genome editing/genome engineering market in 2019. This is due to the increasing prevalence of infectious diseases and cancer, which is driving research in the pharma sector for drug development.

“The Asia Pacific region will register the highest growth in the global genome editing/genome engineering market during the forecast period.”
The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, the rising number of genomic projects, and the presence of a genetically diverse population have supported the region’s high growth rate.

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other directors, and executives from various key organizations operating in the genome editing/genome engineering market.
• By Respondent Type: Supply Side (80%) and Demand Side (20%)
• By Designation: D-level (55%), C-level (20%), and Others (25%)
• By Region: North America (50%), Europe (20%), Asia Pacific (20%), and RoW (10%)

The major companies in the genome editing/genome engineering market include Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Limited (UK), Lonza (Switzerland), GenScript (US), Eurofins Scientific (Luxembourg), and Sangamo Therapeutics (US).
The study includes an in-depth competitive analysis of these key players in the genome editing/genome engineering market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:
The market study covers the genome editing/genome engineering market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, such as products, technology, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall genome editing/genome engineering market and its subsegments. This report will help stakeholders to understand the competitive landscape, gain insights to better position their businesses, and plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide information on the key market drivers, restraints, opportunities, and challenges.

【レポートの目次】

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 20
1.2.1 INCLUSIONS & EXCLUSIONS 20
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 21
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 22
1.7 SUMMARY OF CHANGES 22

2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
2.1.1 SECONDARY DATA 23
2.1.2 PRIMARY DATA 24
2.2 MARKET DATA ESTIMATION & TRIANGULATION 25
2.2.1 DATA TRIANGULATION 25
2.3 MARKET ESTIMATION METHODOLOGY 26
2.4 RESEARCH ASSUMPTIONS 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 31
4.1 GENOME EDITING/GENOME ENGINEERING MARKET OVERVIEW 31
4.2 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY SOLUTION AND COUNTRY (2019) 32
4.3 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION (USD MILLION) 32
4.4 GENOME EDITING/GENOME ENGINEERING MARKET SHARE, BY END USER, 2019 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET DYNAMICS: DRIVERS, OPPORTUNITIES, AND CHALLENGES 34
5.2.1 DRIVERS 34
5.2.1.1 Rising government funding and growth in the number of
genomics projects 34
5.2.1.2 Expanding application areas of genomics 35
5.2.1.3 Introduction of CRISPR-Cas9 35
5.2.2 OPPORTUNITIES 36
5.2.2.1 Extensive use of genome editing in personalized medicine 36
5.2.2.2 Emerging markets 36
5.2.3 CHALLENGES 36
5.2.3.1 High equipment costs 36
5.3 VALUE CHAIN ANALYSIS 37
5.4 IMPACT OF COVID-19 OUTBREAK ON THE GENOME EDITING/GENOME ENGINEERING MARKET 38

6 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY 39
6.1 INTRODUCTION 40
6.2 CRISPR 40
6.2.1 EASE OF USE GIVES CRISPR AN ADVANTAGE OVER OTHER TECHNOLOGIES 40
6.3 TALEN 42
6.3.1 QUICK MODIFICATIONS IN THE GENOME SEQUENCE ARE POSSIBLE WITH TALEN 42
6.4 ZFN 44
6.4.1 EUKARYOTE CELL STUDIES DONE BY ZFN TO DRIVE MARKET GROWTH 44
6.5 ANTISENSE 46
6.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH 46
6.6 OTHER TECHNOLOGIES 48

7 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION 51
7.1 INTRODUCTION 52
7.2 CELL LINE ENGINEERING 52
7.2.1 INCREASING RESEARCH APPLICATIONS OF CELL LINE ENGINEERING TO PROMOTE MARKET GROWTH 52
7.3 GENETIC ENGINEERING 54
7.3.1 ANIMAL GENETIC ENGINEERING 56
7.3.1.1 Use of animal simulation models in research to increase the demand for genome editing 56
7.3.2 PLANT GENETIC ENGINEERING 57
7.3.2.1 Growing attention on GM crops will drive demand for genetic engineering in crops 57
7.4 DIAGNOSTIC APPLICATIONS 57
7.4.1 GROWING APPLICATION HORIZON IN DIAGNOSTICS WILL FAVOR MARKET GROWTH 57
7.5 DRUG DISCOVERY & DEVELOPMENT 59
7.5.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET GROWTH 59
7.6 OTHER APPLICATIONS 61

8 GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE 64
8.1 INTRODUCTION 65
8.2 REAGENTS & CONSUMABLES 65
8.2.1 REAGENTS & CONSUMABLES HOLD THE LARGEST MARKET SHARE 65
8.3 SOFTWARE & SYSTEMS 67
8.3.1 RISING APPLICATION OF GENOME EDITING/SEQUENCING TO INCREASE
THE DEMAND FOR SYSTEMS AND SOFTWARE 67
8.4 SERVICES 69
8.4.1 WIDE APPLICATION OF SERVICES TO INCREASE MARKET GROWTH 69

9 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER 72
9.1 INTRODUCTION 73
9.2 PHARMACEUTICAL COMPANIES 73
9.2.1 CRISPR TECHNOLOGIES ARE USED BY PHARMACEUTICAL COMPANIES FOR APPLICATIONS IN GENE THERAPIES 73
9.3 BIOTECHNOLOGY COMPANIES 75
9.3.1 INCREASING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR MARKET PRODUCTS IN BIOTECH COMPANIES 75
9.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 77
9.4.1 TREND OF COLLABORATIVE RESEARCH WILL SUPPORT MARKET GROWTH 77

10 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION 80
10.1 INTRODUCTION 81
10.2 NORTH AMERICA 82
10.2.1 US 84
10.2.1.1 US dominates the North American market 84
10.2.2 CANADA 86
10.2.2.1 Availability of research funding in Canada drives the market growth 86
10.3 EUROPE 88
10.3.1 UK 90
10.3.1.1 UK is the largest market for genome engineering in Europe 90
10.3.2 FRANCE 92
10.3.2.1 Government funding for genomics and rising investments into research show potential for market growth 92
10.3.3 GERMANY 93
10.3.3.1 Strong academic base and rising awareness are key growth drivers
in Germany 93
10.3.4 REST OF EUROPE 95
10.4 ASIA PACIFIC 97
10.4.1 CHINA 99
10.4.1.1 China to hold the largest share of the market in the Asia Pacific 99
10.4.2 JAPAN 101
10.4.2.1 Focus on cancer research showcases favorable scenario for
the market in Japan 101
10.4.3 INDIA 103
10.4.3.1 Growing number of startups and government support indicates growth potential 103
10.4.4 REST OF ASIA PACIFIC 105
10.5 ROW 106
10.5.1 LATAM 108
10.5.1.1 Latin America is an attractive market for genomics in the RoW 108
10.5.2 MIDDLE EAST & AFRICA 110
10.5.2.1 Rising prevalence of genomic disorders in the Middle East and
the adoption of genetic testing are driving market growth 110

11 COMPETITIVE LANDSCAPE 112
11.1 INTRODUCTION 112
11.2 MARKET RANKING ANALYSIS 112
11.3 MARKET EVALUATION FRAMEWORK 113
11.4 COMPETITIVE LEADERSHIP MAPPING 113
11.4.1 VISIONARY LEADERS 114
11.4.2 DYNAMIC DIFFERENTIATORS 114
11.4.3 INNOVATORS 114
11.4.4 EMERGING COMPANIES 114
11.5 COMPETITIVE SCENARIO 116
11.5.1 KEY PRODUCT LAUNCHES 116
11.5.2 KEY PARTNERSHIPS & COLLABORATIONS 116
11.5.3 KEY ACQUISITIONS 116

12 COMPANY PROFILES 117
(Business overview, Products and Services offered, Recent developments, MNM view)*
12.1 THERMO FISHER SCIENTIFIC 117
12.2 MERCK 119
12.3 HORIZON DISCOVERY 121
12.4 GENSCRIPT 123
12.5 SANGAMO THERAPEUTICS 125
12.6 LONZA 126
12.7 EDITAS MEDICINE 127
12.8 CRISPR THERAPEUTICS 128
12.9 EUROFINS SCIENTIFIC 129
12.10 PRECISION BIOSCIENCES 130
12.11 OXFORD GENETICS 131
12.12 INTELLIA THERAPEUTICS 132
12.13 SYNTHEGO 133
12.14 VIGENE BIOSCIENCES 134
12.15 EPIGENIE 135
12.16 INTEGRATED DNA TECHNOLOGIES 136
12.17 NEW ENGLAND BIOLABS 137
12.18 ORIGENE TECHNOLOGIES 138
12.19 TRANSPOSAGEN BIOPHARMACEUTICALS 139
12.20 CREATIVE BIOGENE 140
*Business overview, Products and Services offered, Recent developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX 141
13.1 DISCUSSION GUIDE 141
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 144
13.3 AVAILABLE CUSTOMIZATIONS 146
13.4 RELATED REPORTS 146
13.5 AUTHOR DETAILS 147

LIST OF TABLES

TABLE 1 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 40
TABLE 2 GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2018–2025 (USD MILLION) 41
TABLE 3 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2018–2025 (USD MILLION) 41
TABLE 4 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR,
BY COUNTRY, 2018–2025 (USD MILLION) 41
TABLE 5 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR,
BY COUNTRY, 2018–2025 (USD MILLION) 42
TABLE 6 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR,
BY REGION, 2018–2025 (USD MILLION) 42
TABLE 7 GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2018–2025 (USD MILLION) 43
TABLE 8 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2018–2025 (USD MILLION) 43
TABLE 9 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN,
BY COUNTRY, 2018–2025 (USD MILLION) 43
TABLE 10 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN,
BY COUNTRY, 2018–2025 (USD MILLION) 44
TABLE 11 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN,
BY REGION, 2018–2025 (USD MILLION) 44
TABLE 12 GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION,
2018–2025 (USD MILLION) 45
TABLE 13 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018–2025 (USD MILLION) 45
TABLE 14 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN,
BY COUNTRY, 2018–2025 (USD MILLION) 45
TABLE 15 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018–2025 (USD MILLION) 46
TABLE 16 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2018–2025 (USD MILLION) 46
TABLE 17 GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2018–2025 (USD MILLION) 47
TABLE 18 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2018–2025 (USD MILLION) 47
TABLE 19 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE,
BY COUNTRY, 2018–2025 (USD MILLION) 47
TABLE 20 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE,
BY COUNTRY, 2018–2025 (USD MILLION) 48
TABLE 21 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE,
BY REGION, 2018–2025 (USD MILLION) 48
TABLE 22 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018–2025 (USD MILLION) 49
TABLE 23 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION) 49

TABLE 24 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION) 49
TABLE 25 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION) 50
TABLE 26 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018–2025 (USD MILLION) 50
TABLE 27 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 52
TABLE 28 GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2018–2025 (USD MILLION) 53
TABLE 29 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION) 53
TABLE 30 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION) 53
TABLE 31 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION) 54
TABLE 32 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2018–2025 (USD MILLION) 54
TABLE 33 GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2018–2025 (USD MILLION) 55
TABLE 34 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION) 55
TABLE 35 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION) 55
TABLE 36 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION) 56
TABLE 37 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2018–2025 (USD MILLION) 56
TABLE 38 GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 57
TABLE 39 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 58
TABLE 40 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 58
TABLE 41 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 58
TABLE 42 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 59
TABLE 43 GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018–2025 (USD MILLION) 60
TABLE 44 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION) 60
TABLE 45 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION) 60
TABLE 46 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 47 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018–2025 (USD MILLION) 61
TABLE 48 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 62

TABLE 49 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 62
TABLE 50 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 62
TABLE 51 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 63
TABLE 52 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 63
TABLE 53 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 65
TABLE 54 GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION) 65
TABLE 55 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 66
TABLE 56 EUROPE: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 66
TABLE 57 APAC: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 66
TABLE 58 ROW: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION) 67
TABLE 59 GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET,
BY REGION, 2018–2025 (USD MILLION) 68
TABLE 60 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 68
TABLE 61 EUROPE: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 68
TABLE 62 APAC: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 69
TABLE 63 ROW: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 69
TABLE 64 GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 70
TABLE 65 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 70
TABLE 66 EUROPE: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 70
TABLE 67 APAC: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 71
TABLE 68 ROW: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET,
BY REGION, 2018–2025 (USD MILLION) 71
TABLE 69 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2018–2025 (USD MILLION) 73
TABLE 70 GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION) 73
TABLE 71 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 74
TABLE 72 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 74
TABLE 73 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 74

TABLE 74 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION) 75
TABLE 75 GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION) 75
TABLE 76 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 77 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 78 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 79 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION) 77
TABLE 80 GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 77
TABLE 81 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY,
2018–2025 (USD MILLION) 78
TABLE 82 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 83 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 84 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 79
TABLE 85 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION,
2018–2025 (USD MILLION) 81
TABLE 86 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 83
TABLE 87 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 83
TABLE 88 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 83
TABLE 89 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 84
TABLE 90 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY END USER, 2018–2025 (USD MILLION) 84
TABLE 91 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 85
TABLE 92 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 85
TABLE 93 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 85
TABLE 94 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2018–2025 (USD MILLION) 86
TABLE 95 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 86
TABLE 96 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 87
TABLE 97 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 87

TABLE 98 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION) 87
TABLE 99 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 88
TABLE 100 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 88
TABLE 101 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 89
TABLE 102 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 89
TABLE 103 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION) 89
TABLE 104 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 90
TABLE 105 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 91
TABLE 106 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 91
TABLE 107 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2018–2025 (USD MILLION) 91
TABLE 108 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 92
TABLE 109 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 92
TABLE 110 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 93
TABLE 111 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION) 93
TABLE 112 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 94
TABLE 113 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 94
TABLE 114 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2017–2025 (USD MILLION) 94
TABLE 115 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION) 95
TABLE 116 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 95
TABLE 117 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 96
TABLE 118 ROE: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 96
TABLE 119 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2018–2025 (USD MILLION) 96
TABLE 120 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 98
TABLE 121 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 98
TABLE 122 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 98

TABLE 123 APAC: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 99
TABLE 124 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2018–2025 (USD MILLION) 99
TABLE 125 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 100
TABLE 126 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 100
TABLE 127 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 100
TABLE 128 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2018–2025 (USD MILLION) 101
TABLE 129 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 101
TABLE 130 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 102
TABLE 131 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 102
TABLE 132 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2018–2025 (USD MILLION) 102
TABLE 133 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 103
TABLE 134 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 104
TABLE 135 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 104
TABLE 136 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2018–2025 (USD MILLION) 104
TABLE 137 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 105
TABLE 138 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 105
TABLE 139 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 106
TABLE 140 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION) 106
TABLE 141 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION,
2018–2025 (USD MILLION) 106
TABLE 142 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 107
TABLE 143 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 107
TABLE 144 ROW: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 107
TABLE 145 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2018–2025 (USD MILLION) 108
TABLE 146 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 108
TABLE 147 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 109

TABLE 148 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 109
TABLE 149 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION) 109
TABLE 150 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 110
TABLE 151 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 110
TABLE 152 MEA: GENOME EDITING/GENOME ENGINEERING MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 111
TABLE 153 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER,
2018–2025 (USD MILLION) 111
TABLE 154 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCH WAS THE MAJOR STRATEGY ADOPTED BY MAJOR PLAYERS IN 2017 113


LIST OF FIGURES

FIGURE 1 BREAKDOWN OF PRIMARIES 24
FIGURE 2 DATA TRIANGULATION METHODOLOGY 25
FIGURE 3 GENOME EDITING/GENOME ENGINEERING MARKET SIZE (USD BILLION) 26
FIGURE 4 GENOME EDITING/GENOME ENGINEERING MARKET CAGR PROJECTIONS FROM AN ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES 26
FIGURE 5 GENOME EDITING/GENOME ENGINEERING MARKET SHARE,
BY APPLICATION, 2019 28
FIGURE 6 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2020−2025 28
FIGURE 7 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 29
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE GENOME EDITING/GENOME ENGINEERING MARKET 30
FIGURE 9 RISING R&D FUNDING AND HIGH PREVALENCE OF INFECTIOUS DISEASES ARE
THE PRIMARY GROWTH DRIVERS FOR THE MARKET 31
FIGURE 10 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET 32
FIGURE 11 CELL LINE ENGINEERING SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019 32
FIGURE 12 PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF
THE MARKET IN 2019 33
FIGURE 13 VALUE CHAIN ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES
MAXIMUM VALUE 37
FIGURE 14 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2020 VS. 2025 81
FIGURE 15 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT 82
FIGURE 16 APAC: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT 97
FIGURE 17 COMPANY RANKING IN THE GENOME EDITING/GENOME ENGINEERING
MARKET, 2019 112
FIGURE 18 GENOME EDITING/GENOME ENGINEERING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019 115
FIGURE 19 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019) 117
FIGURE 20 MERCK: COMPANY SNAPSHOT (2019) 119
FIGURE 21 HORIZON DISCOVERY: COMPANY SNAPSHOT (2018) 121
FIGURE 22 GENSCRIPT: COMPANY SNAPSHOT (2019) 123
FIGURE 23 SANGAMO THERAPEUTICS: COMPANY OVERVIEW (2019) 125
FIGURE 24 LONZA: COMPANY SNAPSHOT (2019) 126
FIGURE 25 EDITAS MEDICINE: COMPANY SNAPSHOT (2018) 127
FIGURE 26 CRISPR THERAPEUTICS: COMPANY SNAPSHOT (2019) 128
FIGURE 27 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 129
FIGURE 28 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2019) 130


★調査レポート[ゲノム編集/ゲノムエンジニアリングの世界市場予測(~2025):技術別、製品・サービス別、用途別、エンドユーザー別、地域別] ( Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025 / BT 3380) 販売に関する免責事項
[ゲノム編集/ゲノムエンジニアリングの世界市場予測(~2025):技術別、製品・サービス別、用途別、エンドユーザー別、地域別] ( Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025 / BT 3380) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆